Alexa

Actos Bellwether Case Goes to Trial

First Actos Bellwether Case on Trial

The first bellwether case in the multidistrict litigation (MDL) against Actos, manufactured by pharmaceutical company Takeda Pharmaceuticals, began on January 27th in the US District Court of Western Louisiana.

The MDL currently has 2,800 cases alleging that Actos caused bladder cancer and other serious side effects.

The Actos personal injury case was filed by plaintiff Terrence Allen, who was prescribed Actos in 2004 and took the drug for 7 years. In 2011, Allen was diagnosed with bladder cancer. His complaint alleges that Takeda Pharmaceuticals failed to warn doctors and patients of the dangers of taking Actos – had he and his doctor known about the increased risk for developing bladder cancer, Allen would have been prescribed a different medication to treat his Type 2 diabetes. The complaint alleges that Takeda intentionally withheld the information.

Previous bellwether cases in the Actos MDL had been scheduled, but vacated due to various legal technicalities. For example, last year’s bellwether case involving plaintiff Jack Cooper, who was initially awarded $6.5 million for pain and suffering, was nullified after an appeal from Takeda. The judge nullified the initial verdict stating that testimony given by the doctor was “inherently unreliable.”

Allen’s Actos lawsuit is the first bellwether case to successfully make it to trial against Takeda, and is expected to last 6 weeks.

Actos Linked to Serious Personal Injury

The FDA is currently investigating the risks of taking Actos, and says their review will wrap up next year. Based on evidence from new studies, the government agency issued a warning against Actos and said Takeda had to package their drug with the strongest possible warning label. Meanwhile, both France and Germany banned the drug from sale in their countries, and most recently, India temporarily banned Actos and the generic form pioglitazone, but after confrontations with doctors, rescinded the ban pending further study. The generic form of Actos, pioglitazone, was approved for use by the FDA in August 2013.

Takeda Pharmaceuticals pointed out that patients with Type 2 diabetes have an increased risk of developing bladder cancer anyway. However, multiple studies on Actos’s effectiveness in recent years have shown that the drug increases patients’ risk of developing a variety of serious diseases, including diabetic macular edema, and bladder cancer.

There are several side effects associated with Actos.  You should seek medical attention if you experience:

  • shortness of breath or trouble breathing,
  • chest pain,
  • extreme fatigue,
  • irregular heartbeat,
  • dilated neck veins,
  • swelling of face, fingers, feet, or lower legs,
  • decreased urine output, and
  • weight gain

The Strom Law Firm Can Help with Personal Injury and Wrongful Death Cases, Including Against Actos

If you or a loved one have taken Actos to treat Type 2 diabetes, and have since suffered dangerous side effects including developing bladder cancer, heart disease, liver failure, or diabetic macular edema, you may be entitled to compensation. The attorneys at the Strom Law Firm can help with personal injury cases, including against Actos manufacturer Takeda Pharmaceuticals. We offer free, confidential consultations to discuss the facts of your case, so do not hesitate to contact us803.252.4800

About Pete Strom

Defending criminal charges including drug crimes, DUI, CDV, mail fraud, wire fraud, bank fraud, computer crimes, money laundering, and juvenile crimes, Pete also handles Federal and State investigations. Representing individuals in Civil Matters including Class Actions, Personal Injury, Qui Tam Actions, Defective Products, Nursing Home Neglect, and Professional Licensing Defense cases. Joseph Preston “Pete” Strom, Jr., the managing partner at Strom Law Firm, L.L.C., has been fighting for justice since 1984.

Leave a Reply

BestLawyers.comAVBetter Business Bureau